ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 86 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,349 | +145.3% | 135,894 | +71.8% | 0.02% | +100.0% |
Q4 2022 | $550 | -99.9% | 79,092 | -28.9% | 0.01% | +100.0% |
Q1 2022 | $494,000 | +558.7% | 111,165 | +487.1% | 0.00% | – |
Q4 2021 | $75,000 | -90.4% | 18,933 | -71.1% | 0.00% | -100.0% |
Q1 2021 | $778,000 | -4.8% | 65,539 | -45.0% | 0.01% | -50.0% |
Q4 2020 | $817,000 | +152.2% | 119,207 | +53.3% | 0.02% | +60.0% |
Q2 2020 | $324,000 | – | 77,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |